LARP1 and hemoglobin measurement: In conclusion, these findings provide a novel oncogenic mechanism of the circCLNS1A/LARP1/DKK4 cascade, a basis for targeting O‐GlcNAcylated LARP1 as a therapeutic strategy, and the potential of serum DKK4 as a diagnostic and prognostic biomarker for HB.